| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Brentuximab vedotin in Hodgkin lymphoma and systemic anaplastic large-cell lymphoma
|
Abraham, Jame
|
|
2012
|
9 |
1 |
p. 5-7
3 p.
|
artikel
|
| 2 |
Brentuximab vedotin ushers in a new era in treating lymphomas
|
Cheson, Bruce D.
|
|
2012
|
9 |
1 |
p. 3-4
2 p.
|
artikel
|
| 3 |
Community-based surveillance in clinical stage I germ cell tumors
|
Perkins, James
|
|
2012
|
9 |
1 |
p. 15-19
5 p.
|
artikel
|
| 4 |
Contents
|
|
|
2012
|
9 |
1 |
p. A7-
1 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2012
|
9 |
1 |
p. A5-
1 p.
|
artikel
|
| 6 |
Embracing the ‘new normal’
|
Bosserman, Linda D.
|
|
2012
|
9 |
1 |
p. 31-33
3 p.
|
artikel
|
| 7 |
Facing the challenges of the next 8 years
|
Henry, David H.
|
|
2012
|
9 |
1 |
p. 1-
1 p.
|
artikel
|
| 8 |
FDA issues new rule on drug shortages
|
Ault, Alicia
|
|
2012
|
9 |
1 |
p. 34-
1 p.
|
artikel
|
| 9 |
Oncology's transitional generation: charting the way to integrated, efficient, and cost-effective delivery systems
|
Bosserman, Linda D.
|
|
2012
|
9 |
1 |
p. 2-
1 p.
|
artikel
|
| 10 |
PRES—a potential side effect of gemcitabine
|
Modi, Niyati
|
|
2012
|
9 |
1 |
p. 27-28
2 p.
|
artikel
|
| 11 |
Retrospective study of patients with metastatic triple-negative breast cancer: survival, health care utilization, and cost
|
Baser, Onur
|
|
2012
|
9 |
1 |
p. 8-14
7 p.
|
artikel
|
| 12 |
Severe and rapid cardiac toxicity from sunitinib therapy in a patient with metastatic renal cell carcinoma
|
Furman, Michael
|
|
2012
|
9 |
1 |
p. 29-30
2 p.
|
artikel
|
| 13 |
Treatment of chemotherapy-induced nausea
|
Navari, Rudolph M.
|
|
2012
|
9 |
1 |
p. 20-26
7 p.
|
artikel
|
Tijdschrift beschrijving